Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-12-04 16:37 Tx date 2023-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+133,333 vol |
239,380 | |
Filed 2023-12-04 16:36 Tx date 2023-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-133,333 vol |
266,667 | |
Filed 2023-01-04 17:45 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+6,047 vol |
106,047 | |
Filed 2023-01-04 17:42 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,047 vol |
400,000 | |
Filed 2023-01-04 17:18 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,047 vol |
406,047 | |
Filed 2022-10-05 17:31 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-400,000 vol |
0 | |
Filed 2022-10-05 17:27 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$564,000
+400,000 vol $1.41 each |
400,000 | |
Filed 2022-10-05 17:23 Tx date 2021-03-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-04-16 16:43 Tx date 2021-04-12 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
46 - Compensation for services
|
$423,000
+100,000 vol $4.23 each |
100,000 | |
Filed 2021-04-04 13:48 Tx date 2021-03-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,804,000
+400,000 vol $4.51 each |
400,000 | |
Filed 2021-04-04 13:44 Tx date 2021-03-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-04-04 13:43 Tx date 2021-03-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|